[Baveno VII - Renewing consensus in portal hypertension: personalized care for portal hypertension]

Zhonghua Gan Zang Bing Za Zhi. 2022 Jan 20;30(1):21-29. doi: 10.3760/cma.j.cn501113-20220109-00010.
[Article in Chinese]

Abstract

The Baveno VII workshop held in October 2021 was featured by the subject of personalized care in portal hypertension. The workshop focused on the following 9 topics including: the relevance and indications for measuring the hepatic venous pressure gradient as a gold standard; the use of non-invasive tools for the diagnosis of compensated advanced chronic liver disease and clinically significant portal hypertension; the impact of etiological and of non-etiological therapies in the course of cirrhosis; the prevention of the first episode of decompensation; the management of the acute bleeding episode; the prevention of further decompensation; as well as the diagnosis and management of splanchnic vein thrombosis and other vascular disorders of the liver. This essay provides a compilation and summary of recommendations regarding the abovementioned topics, and presents the most recent research proceedings and the corresponding consensus to our readers.

2021年10月召开的Baveno Ⅶ共识会的主题是"门静脉高压的个体化治疗"。主要讨论了9个主题,包括:把测量肝静脉压力梯度作为诊断金标准;非侵入性方法诊断代偿进展期慢性肝病和临床有意义的门静脉高压;病因治疗和非病因治疗对肝硬化的影响;预防首次失代偿;急性静脉曲张出血;预防进一步失代偿;以及内脏静脉血栓和其他肝脏血管病。本文对上述主题的推荐进行编译汇总,把国际上门静脉高压最前沿的研究成果和借此形成的共识意见呈现给读者。.

Keywords: Compensated advanced chronic liver disease; Liver cirrhosis; Personalized care; Portal hypertension; Portal vein thrombosis; Vascular liver diseases.

MeSH terms

  • Consensus
  • Esophageal and Gastric Varices*
  • Humans
  • Hypertension, Portal* / therapy
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / therapy
  • Portal Pressure